La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Hikma Pharmaceuticals Salute del bilancio
Salute finanziaria criteri di controllo 4/6
Hikma Pharmaceuticals ha un patrimonio netto totale di $2.3B e un debito totale di $1.2B, che porta il suo rapporto debito/patrimonio netto a 53.2%. Le sue attività totali e le sue passività totali sono rispettivamente $4.8B e $2.5B. L'EBIT di Hikma Pharmaceuticals è $712.0M rendendo il suo rapporto di copertura degli interessi 11. Ha liquidità e investimenti a breve termine pari a $260.0M.
Informazioni chiave
53.2%
Rapporto debito/patrimonio netto
US$1.22b
Debito
| Indice di copertura degli interessi | 11x |
| Contanti | US$260.00m |
| Patrimonio netto | US$2.30b |
| Totale passività | US$2.55b |
| Totale attività | US$4.85b |
Aggiornamenti recenti sulla salute finanziaria
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02
Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Recent updates
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 11Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate
Aug 01Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?
Apr 24Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Apr 02Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion
Feb 25Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Dec 27An Intrinsic Calculation For Hikma Pharmaceuticals PLC (LON:HIK) Suggests It's 43% Undervalued
Dec 12Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Sep 19Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Sep 01Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Jun 21Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 28% Above Its Share Price
Jun 02Hikma Pharmaceuticals (LON:HIK) Has A Pretty Healthy Balance Sheet
Mar 14Calculating The Intrinsic Value Of Hikma Pharmaceuticals PLC (LON:HIK)
Feb 21Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?
Sep 27Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 19% Below Its Share Price
Jun 24These 4 Measures Indicate That Hikma Pharmaceuticals (LON:HIK) Is Using Debt Reasonably Well
Jun 06Here's Why Hikma Pharmaceuticals (LON:HIK) Can Manage Its Debt Responsibly
Feb 26Hikma Pharmaceuticals PLC's (LON:HIK) Intrinsic Value Is Potentially 92% Above Its Share Price
Dec 01Is Hikma Pharmaceuticals (LON:HIK) Using Too Much Debt?
Nov 11Is There An Opportunity With Hikma Pharmaceuticals PLC's (LON:HIK) 32% Undervaluation?
Sep 02Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?
Aug 09Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 26% Below Their Intrinsic Value Estimate
May 21Hikma Pharmaceuticals (LON:HIK) Seems To Use Debt Quite Sensibly
May 03It's Unlikely That Hikma Pharmaceuticals PLC's (LON:HIK) CEO Will See A Huge Pay Rise This Year
Apr 16How Does Hikma Pharmaceuticals PLC (LON:HIK) Stand Up To These Simple Dividend Safety Checks?
Apr 13Hikma Pharmaceuticals PLC (LON:HIK) Looks Interesting, And It's About To Pay A Dividend
Mar 14Hikma Pharmaceuticals PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Feb 28Analisi della posizione finanziaria
Passività a breve termine: Le attività a breve termine ( $2.3B ) di HIK superano le sue passività a breve termine ( $1.4B ).
Passività a lungo termine: Le attività a breve termine di HIK ( $2.3B ) superano le sue passività a lungo termine ( $1.2B ).
Storia e analisi del rapporto debito/patrimonio netto
Livello di debito: Il rapporto debito netto/patrimonio netto ( 41.9% ) di HIK è considerato alto.
Riduzione del debito: Il rapporto debito/patrimonio netto di HIK è aumentato da 34.1% a 53.2% negli ultimi 5 anni.
Copertura del debito: Il debito di HIK è ben coperto dal flusso di cassa operativo ( 47.8% ).
Copertura degli interessi: I pagamenti degli interessi sul debito di HIK sono ben coperti dall'EBIT ( 11 x copertura).